Generation Bio CO Form 4 insider transactions

Antoinette Paone, Chief Operating Officer of Generation Bio Co., reports the vesting and subsequent disposal of shares related to restricted stock units.

Yalonda Howze, Chief Legal Officer of Generation Bio Co., reports the vesting and subsequent sale of restricted stock units.

Yalonda Howze, Chief Legal Officer of Generation Bio Co., reports the vesting and subsequent disposal of restricted stock units.

CEO Geoff McDonough reports the vesting of restricted stock units and associated tax withholding, along with adjustments to shares held directly and indirectly through family trusts.

Matthew Norkunas, CFO of Generation Bio Co., reports acquisition and disposal of common stock and restricted stock units on July 15, 2024.

Antoinette Paone, Chief Operating Officer of Generation Bio Co., reports the vesting and subsequent disposal of shares to cover tax obligations.

Phillip Samayoa, Chief Strategy Officer at Generation Bio Co., reports the vesting and subsequent sale of restricted stock units, along with adjustments to common stock holdings.

Matthew Stanton, Chief Scientific Officer of Generation Bio Co., reports the vesting and subsequent disposal of shares related to restricted stock units.

Antoinette Paone, Chief Operating Officer of Generation Bio Co., sold 6,719 shares of common stock at $2.74 per share on July 1, 2024, under a pre-arranged trading plan.

Director Jason P. Rhodes acquired 60,000 stock options in Generation Bio Co. on June 6, 2024, with vesting contingent on future events.

Catherine Stehman-Breen, a director of Generation Bio Co., acquired stock options for 60,000 shares on June 6, 2024.

Charles A. Rowland Jr., a director of Generation Bio Co., acquired 60,000 stock options on June 6, 2024, at an exercise price of $3.32.

Anthony G. Quinn, a director of Generation Bio Co., was granted stock options to purchase 60,000 shares of common stock at $3.32 per share on June 6, 2024.

Ronald Harold Wilfred Cooper, a director of Generation Bio Co., was granted stock options to purchase 60,000 shares of common stock on June 6, 2024.

Director Gustav Christensen of Generation Bio Co. was granted stock options to purchase 60,000 shares of common stock on June 6, 2024.

Director Jeffrey M. Jonas acquired 60,000 stock options in Generation Bio Co. on June 6, 2024, at an exercise price of $3.32.

Director Donald William Nicholson acquired 60,000 stock options in Generation Bio Co. on June 6, 2024.

Director Dannielle Appelhans of Generation Bio Co. reports the acquisition of stock options.

Chief Scientific Officer Matthew Stanton reports the vesting and subsequent disposal of Generation Bio Co. common stock to cover tax obligations.

Phillip Samayoa, Chief Strategy Officer at Generation Bio Co., reports the vesting and subsequent disposal of restricted stock units.

Antoinette Paone, Chief Operating Officer of Generation Bio Co., reports the vesting and subsequent disposal of shares to cover tax obligations.

Matthew Norkunas, Chief Financial Officer of Generation Bio Co., reports the vesting and subsequent sale of restricted stock units.

CEO Geoff McDonough reports acquisition and disposal of Generation Bio Co. common stock and restricted stock units.

Yalonda Howze, Chief Legal Officer of Generation Bio Co., reports the vesting of restricted stock units and subsequent tax withholding.